
Historically, women and minorities were excluded from clinical trials, leading to gender disparities in medical research. In the 2000s, research on women’s health, especially sex-biased diseases like Alzheimer’s, gained attention. Women now represent two-thirds of Alzheimer’s patients, but the mechanisms behind their increased susceptibility remain unclear. Notable studies, like the Women’s Health Initiative Memory Study (WHIMS), are investigating the role of female sex hormones in Alzheimer’s.
Like
Save
Share